Skip to main content

Albuterol sulfate and Ipratropium Bromide Inhalation Solution Shortage

Last Updated: May 2, 2024
Status: Current

Products Affected - Description
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 69097-0840-64 - discontinued
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 69097-0840-53 - discontinued
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg/ 0.5 mg, 3 mL 30 vials per carton/5 vials per foil pouch NDC 69097-0173-53
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 60 vials per carton/5 vials per foil pouch NDC 00487-0201-60
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 30 vials per carton/5 vials per foil pouch NDC 00487-0201-03
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 00487-0201-01
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 76204-0600-01
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 30 vials per carton/30 vial per foil pouch NDC 76204-0600-30
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 60 vials per carton/30 vial per foil pouch NDC 76204-0600-60
Reason for the Shortage
    • Cipla did not provide a reason for the shortage.
    • Mylan has albuterol and ipratropium inhalation solution available.
    • Nephron is shipping albuterol and ipratropium inhalation solution regularly. Nephron states demand has recently increased for product.
    • Ritedose did not provide a reason for the shortage.
    • Sun Pharma has albuterol and ipratropium inhalation solution available.
Available Products
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 69097-0173-64
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 69097-0840-87
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 30 vials per carton/30 vial per foil pouch NDC 00378-9671-30
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 60 vials per carton/30 vial per foil pouch NDC 00378-9671-60
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 00378-9671-93
    • Albuterol sulfate and ipratropium bromide inhalation solution, Sun Pharma, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 47335-0756-52
    • Albuterol sulfate and ipratropium bromide inhalation solution, Sun Pharma, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 47335-0756-49

Estimated Resupply Dates

    • Cipla has albuterol and ipratropium 3 mL inhalation solution in 30 count (5 vials per foil pouch) on back order and the company cannot estimate a release date.
    • Nephron has all presentations on intermittent back order and the company is releasing supplies as they become available.
    • Ritedose has all presentations on allocation.

Updated

Updated May 2, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 13, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer